Gene-Tailored diabetes care tested in major trial
NCT ID NCT06851962
First seen Mar 06, 2026 · Last updated May 07, 2026 · Updated 9 times
Summary
This study tests whether choosing diabetes medication based on a person's genetic profile helps control blood sugar better than standard care. About 504 adults with poorly controlled type 2 diabetes will receive either genetically guided or standard treatment. Researchers will compare how many reach their blood sugar goal after 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clínico Universitario de Valencia
Valencia, 46010, Spain
-
Hospital General Universitario de Valencia (HGUV)
Valencia, 46014, Spain
-
Hospital Universitario Regional de Málaga
Málaga, 29010, Spain
Conditions
Explore the condition pages connected to this study.